113 related articles for article (PubMed ID: 2784234)
1. Quantitative estimation of elastase-alpha 1-proteinase inhibitor (E-alpha 1 PI) complex in leukemia: marked elevation in cases of acute promyelocytic leukemia.
Saito M; Asakura H; Uotani C; Jokaji H; Kumabashiri I; Matsuda T
Thromb Res; 1989 Jan; 53(2):163-71. PubMed ID: 2784234
[TBL] [Abstract][Full Text] [Related]
2. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
Soma M; Maeda Y; Kasakura S; Yabe H
Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of human granulocytic elastase alpha 1-proteinase inhibitor complex (E-alpha 1-PI) in leukemia.
Hiller E; Jochum M
Blut; 1984 May; 48(5):269-75. PubMed ID: 6372901
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
5. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
6. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of plasma thrombomodulin in chronic myelogenous leukemia.
Morishita E; Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Matsuda T
Am J Hematol; 1992 Mar; 39(3):183-7. PubMed ID: 1312301
[TBL] [Abstract][Full Text] [Related]
9. Relationship between elevation in the plasma concentration of elastase-alpha 1 proteinase inhibitor complex (E-alpha 1 PI) and haemostatic parameters during haemodialysis.
Yamazaki M; Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Aoshima K; Sato T; Tsugawa Y
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):5-10. PubMed ID: 7795153
[TBL] [Abstract][Full Text] [Related]
10. The importance of granulocyte elastase in haematological diagnosis.
Hastka J
Blut; 1988 Aug; 57(2):69-75. PubMed ID: 3165679
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
12. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase alpha 1-proteinase inhibitor complexes in pleural effusions.
Klech H; Rona G; Knoth E; Kummer F; Bayer PM
Klin Wochenschr; 1988 Apr; 66(8):346-50. PubMed ID: 3260636
[TBL] [Abstract][Full Text] [Related]
15. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure.
Pacher R; Redl H; Frass M; Petzl DH; Schuster E; Woloszczuk W
Crit Care Med; 1989 Mar; 17(3):221-6. PubMed ID: 2784090
[TBL] [Abstract][Full Text] [Related]
16. Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.
Bergenfeldt M; Ohlsson K
Gastroenterol Jpn; 1993 Oct; 28(5):687-98. PubMed ID: 8224620
[TBL] [Abstract][Full Text] [Related]
17. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
[TBL] [Abstract][Full Text] [Related]
18. Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space.
Burkhardt H; Kasten M; Rauls S; Rehkopf E
Rheumatol Int; 1987; 7(3):133-8. PubMed ID: 3313660
[TBL] [Abstract][Full Text] [Related]
19. The role of inter-alpha-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin.
Pratt CW; Roche PA; Pizzo SV
Arch Biochem Biophys; 1987 Nov; 258(2):591-9. PubMed ID: 2445291
[TBL] [Abstract][Full Text] [Related]
20. Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elastase.
Pacholok SG; Davies P; Dorn C; Finke P; Hanlon WA; Mumford RA; Humes JL
Biochem Pharmacol; 1995 May; 49(10):1513-20. PubMed ID: 7763294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
